Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

被引：9
|
作者：
Nagel, Sylke [3 ]
Califano, Raffaele [2 ]
Thatcher, Nicholas [1 ]
Blackhall, Fiona [1 ]
机构：
[1] Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Osped Santa Maria Misericordia, SC Oncol Med, I-06120 Perugia, Italy
[3] Martha Maria Hosp, D-06120 Halle, Germany
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 18期
关键词：
carboplatin; chemotherapy; gemcitabine; non-small-cell lung cancer;
D O I：
10.1517/14656566.8.18.3265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status is a platinum drug in combination with one of gemcitabine, paclitaxel, vinorelbine or docetaxel. Although cisplatin is generally the favoured platinum agent, gemcitabine partnered with carboplatin is convenient to administer and has a favourable toxicity profile. Here, the pharmacology, preclinical and clinical data to support the use of this regimen for the treatment of advanced non-small-cell lung cancer is evaluated.
引用
收藏
页码：3265 / 3275
页数：11
相关论文
共 50 条
  • [1] Gemcitabine and carboplatin in the treatment of locally advanced and metastatic non-small cell lung cancer
    Leow, CH
    Liam, CK
    [J]. RESPIROLOGY, 2005, 10 (05) : 629 - 635
  • [2] Gemcitabine/carboplatin in advanced non-small cell lung cancer
    Zatloukal, P
    Petruzelka, L
    [J]. LUNG CANCER, 2002, 38 : S33 - S36
  • [3] Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?
    Saha, Antonio
    Rudd, Robin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (02) : 165 - 173
  • [4] Gemcitabine and carboplatin combination in patients with advanced and locally advanced stage non-small cell lung cancer
    Ozturk, Nevzat
    Erbaycu, Ahmet Emin
    Gulpek, Mehmet
    Tuksavul, Fevziye
    Uslu, Ozgur
    Guclu, Salih Zeki
    [J]. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, 2008, 23 (02): : 72 - 80
  • [5] Gemcitabine and carboplatin for patients with advanced non-small cell lung cancer
    Dómine, M
    Casado, V
    Estévez, LG
    León, A
    Martin, JI
    Castillo, M
    Rubio, G
    Lobo, F
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (03) : 4 - 9
  • [6] THE COMBINATION CHEMOTHERAPY OF GEMCITABINE, CARBOPLATIN AND BEVACIZUMAB IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Kim, Bong Seog
    Ahn, Young Mi
    Lee, Moon Hyung
    Suh, Kang Heum
    Nam, Seung-Hyun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1158 - S1158
  • [7] The Combination Chemotheray of Gemcitabine, Carboplatin and Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer
    Lee, Moon-Hyung
    Whang, Jin Ah
    Ahn, Young Mee
    Noh, Yong Ho
    Nam, Seung Hyun
    Kim, Bong-Seog
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S402 - S402
  • [8] Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer
    Belani, CP
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 4 - 9
  • [9] Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Park, SH
    Jeong, SH
    Kyung, SY
    Lim, YH
    An, CH
    Lee, SP
    Park, JW
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    [J]. MEDICAL ONCOLOGY, 2005, 22 (04) : 359 - 366
  • [10] Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer
    Harper, P
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (04) : 2 - 12
12345